Cite
HARVARD Citation
Fernández-Eulate, G. et al. (2019). Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement. BMJ case reports. 12 (11), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fernández-Eulate, G. et al. (2019). Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement. BMJ case reports. 12 (11), p. . [Online].